Back
CytomX Therapeutics Stock Predictions
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
38
CTMX
CytomX Therapeutics
Last Price:
$1.08
Seasonality Move:
-0.08%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.CytomX Therapeutics Stock Forecast
-
Is CytomX Therapeutics Stock Undervalued?The current CytomX Therapeutics [CTMX] share price is $1.09. The Score for CTMX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CTMX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will CytomX Therapeutics Stock Go Up Next Year?
Data Unavailable
CytomX Therapeutics Stock Rating
Data Unavailable
CytomX Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomx.com
52-Week Data
52-Week High:
5.85
52-Week Low:
0.83
Prediction Charts
Market Cap:
85.3M
Price in USD:
1.09
Volume:
1.3M
Beta:
0.94
Technical Analysis
SMA50:
1.06
SMA100:
1.13
SMA200:
1.51
52-Wk Change:
-24.31%
Stock Predictions
-
Is CytomX Therapeutics stock public?Yes, CytomX Therapeutics is a publicly traded company.
-
What is the CytomX Therapeutics stock quote today?The CytomX Therapeutics stock price is 1.09 USD today.
-
How to buy CytomX Therapeutics stock online?You can buy CytomX Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 1.22 | 1.29 | 1.42 | 1.21 |
| Dec-5 | 1.27 | 1.16 | 1.28 | 1.13 |
| Dec-6 | 1.19 | 1.18 | 1.25 | 1.17 |
| Dec-9 | 1.23 | 1.26 | 1.28 | 1.19 |
| Dec-10 | 1.24 | 1.21 | 1.25 | 1.17 |
| Dec-11 | 1.24 | 1.18 | 1.25 | 1.15 |
| Dec-12 | 1.17 | 1.12 | 1.17 | 1.08 |
| Dec-13 | 1.13 | 1.11 | 1.13 | 1.05 |
| Dec-16 | 1.12 | 1.15 | 1.16 | 1.09 |
| Dec-17 | 1.14 | 1.13 | 1.15 | 1.06 |
| Dec-18 | 1.12 | 1.06 | 1.12 | 1.00 |
| Dec-19 | 1.07 | 1.10 | 1.13 | 1.03 |
| Dec-20 | 1.06 | 1.09 | 1.10 | 1.03 |
| Dec-23 | 1.06 | 1.09 | 1.11 | 1.05 |
CytomX Therapeutics Earnings
Data Unavailable
CytomX Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.44 per share.
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.